ABT - Abbott Laboratories
114.23
| Index: | S&P 500 | P/E: | 34.74 | EPS (ttm): | 3.29 | Insider Own: | 0.66% | Shs Outstand: | 1.73B | Perf Week: | 0.75% |
| Market Cap: | 201.32B | Forward P/E: | 22.13 | EPS next Y: | 5.16 | Insider Trans: | -2.51% | Shs Float: | 1.72B | Perf Month: | -1.47% |
| Income(ttm): | 5.75B | PEG: | 4.26 | EPS next Q: | 1.34 | Inst Own: | 76.62% | Short Float: | 0.79% | Perf Quarter: | -0.51% |
| Revenue(ttm): | 41.22B | P/S: | 4.88 | EPS this Y: | 5.28% | Inst Trans: | -1.00% | Short Ratio: | 2.67 | Perf Half Y: | 8.48% |
| Book/sh: | 22.94 | P/B: | 4.98 | EPS next Y: | 10.40% | ROA: | 7.85% | Short Interest: | 13.57M | Perf Year: | 6.36% |
| Cash/sh: | 4.42 | P/C: | 25.85 | EPS next 5Y: | 8.15% | ROE: | 14.87% | 52W Range: | 99.71 - 121.64 | Perf YTD: | 3.78% |
| Dividend Est.: | 2.21 (1.94%) | P/FCF: | 31.04 | EPS past 5Y: | 19.65% | ROI: | 10.92% | 52W High: | -6.09% | Beta: | 0.73 |
| Dividend TTM: | 2.20 (1.93%) | Quick Ratio: | 1.14 | Sales past 5Y: | 6.10% | Gross Margin: | 50.98% | 52W Low: | 14.56% | ATR (14): | 1.91 |
| Dividend Ex-Date: | Jan 15, 2025 | Current Ratio: | 1.60 | EPS Y/Y TTM: | 11.65% | Oper. Margin: | 16.38% | RSI (14): | 46.70 | Volatility: | 1.75% 1.58% |
| Employees: | 114000 | Debt/Eq: | 0.38 | Sales Y/Y TTM: | 3.15% | Profit Margin: | 13.94% | Recom: | 1.72 | Target Price: | 131.82 |
| Option/Short: | Yes / Yes | LT Debt/Eq: | 0.32 | EPS Q/Q: | 14.65% | Payout: | 63.81% | Rel Volume: | 2.35 | Prev Close: | 112.42 |
| Sales Surprise: | 0.80% | EPS Surprise: | 0.65% | Sales Q/Q: | 4.85% | Earnings: | Oct 16 BMO | Avg Volume: | 5.08M | Price: | 114.23 |
| SMA20: | -1.02% | SMA50: | -1.51% | SMA200: | 3.22% | Undervalued: 15.4% | Volume: | 11,945,003 | Change: | 1.61% | |
Graham Classic formula value: 73.27
(P/E=8 * 1g) Min value: 47.71
(current P/E * 2g) Max value: 150.79
Average value: 90.59
Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products. It operates through the following business segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Medical Devices segment includes electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.
Attention! Trading on the stock market involves financial risks and is not suitable for everyone. The www.stocks-expert.com does not provide financial market trading services; it is for informational purposes only and is not responsible for the consequences of your trading decisions or the operation of the software. Before starting to trade in any markets, make sure you understand the risks associated with trading and that you have a sufficient level of training.